期刊文献+

甘肃汉族妇女XRCC1和CCNH基因多态性与乳腺癌及乳腺良性肿瘤易感性研究

The relevance of XRCC1 and CCNH gene polymorphism to breast cancer and benign breasttumor in Han women of Gansu province
下载PDF
导出
摘要 目的:研究甘肃地区汉族妇女XRCC1 rs25487、CCNH rs2234942基因多态性与乳腺癌及乳腺良性肿瘤发病的相关性。方法:选取经病理组织学确诊的乳腺癌、乳腺良性肿瘤各101例,匹配相同数量健康人作对照。使用聚合酶链式反应-限制性片段长度多态分析技术(PCR-RFLP)对XRCC1、CCNH进行基因型分析,通过Logistic回归分析不同基因型和临床病理特征与乳腺癌发病2的风险性关系,通过检验比较两种基因位点不同基因型的初潮年龄、发病年龄与乳腺癌和乳腺良性肿瘤的相关性。结果:Logistic回归分析发现XRCC1 rs25487位点GG基因型携带者的妇女罹患乳腺癌的危险性增加(P=0.001,OR=6.39,95%CI:2.18^+-18.65);临床病理免疫组化分析显示,XRCC1基因rs25487位点携带AA/AG基因型者,在PR与PR乳腺癌组织间的分布差异有显著+-2性(P=0.04,OR=0.29);携带AG/GG基因型者,在Her-2与Her-2乳腺癌组织间的分布差异有显著性(P=0.008,OR=0.45)。检验显示,乳腺癌和乳腺良性肿瘤患者XRCC1 rs25487位点GG/AG基因型携带者的初潮年龄差异有显著性(P=0.001、0.043);乳腺癌和乳腺良性肿瘤患者CCNH rs2234942位点GG基因型携带者的初潮年龄差异有显著性(P=0.049);乳腺癌和乳腺良性肿瘤患者XRCC1rs25487和CCNH rs2234942位点GG基因型携带者,发病年龄差异有显著性(P=0.019、0.048)。结论:XRCC1 rs25487 GG基因型将会+增加乳腺癌的发病风险,XRCC1 rs25487位点携带AA/AG基因型者,在PR时乳腺癌的发病风险下降;携带AG/GG基因型者,在+Her-2时可能降低乳腺癌的发病风险。 To study the association between XRCC1 rs25487 and CCNH rs2234942 polymorphism with the susceptibility to breast cancer and benign breast tumor in Han women in Gansu area. METHODS:Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was used for the polymorphism of XRCC1,CCNH in 101 cases of breast cancer,101 benign breast tumors and 101 disease-free controls collected in Gansu. Logistic regression analysis was used for comparing the genotypes or clinical pathological characteristics with the risk of breast cancer. Chi-square test was used to compare menarche age and disease onset age with the risk of breast cancer or benign tumor. RESULTS:Logistic regression analysis showed that XRCC1 rs25487,GG genotype increased the risk of breast cancer (P=0.001,OR=6.39,95%CI:2.18-18.65). Regarding the clinicopathological immunohistochemical characteristics,the distribution of AA/AG genotype was significantly different+ -between PR and PR at XRCC1 rs25487(P=0.04,OR=0.29),while the distribution of AG/GG genotype was significantly+ -different in Her-2 cases and Her-2 (P=0.008,OR=0.45). Chi-square test found that the menarche age of GG/AG genotype in XRCC1 rs25487 and GG genotype in CCNH rs2234942 was significantly different in breast cancer and benign tumor (P=0.001,0.043,0.049). The disease onset age of GG genotype in both XRCC1 rs25487 and CCNH rs2234942 was significantly different in breast cancer and benign tumor(P=0.019,0.048). CONCLUSION:GG genotype in+XRCC1 rs25487 increased the risk of breast cancer. AA/AG genotype in XRCC1 rs25487 with PR and AG/GG genotype in+CCNH rs2234942 with Her-2 reduced the risk of breast cancer.
出处 《癌变.畸变.突变》 CAS CSCD 2014年第4期292-297,共6页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 甘肃省科技厅支撑项目(1011FKCA089) 甘肃省卫生行业计划项目(GSWST2010-08)
关键词 XRCC1 CCNH 基因多态性 乳腺癌 XRCC1 CCNH SNPs breast cancer
  • 相关文献

参考文献17

  • 1Yang L, Parkin DM, Feday J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005[J].Cancer EpidemiolBiomarkers Prey, 2005, 14(1): 243-250.
  • 2Fentiman IS. Fixed and modifiable risk factors for breast eancer[J].IntJClinPract, 2001, 55(8): 527-530.
  • 3Coughlin SS, Piper M. Genetic polymotphisms and risk of breast cancer[J]. Cancer Epidemiol Biomarkers Prey, 1999, 8(11): 1023-1032.
  • 4Patel SA, Simon MC. Functional analysis of the Cdk7 cyclin H Marl complex in mouse embryonic stem cells and embryos[J]. BiolChem, 2010, 285(20): 15587-15598.
  • 5王杉,梁斌,乔新民,严飞飞,崔志荣.细胞周期素H和细胞周期素依赖性激酶7在人乳腺癌组织中的表达及其意义[J].中华普通外科杂志,2002,17(10):611-613. 被引量:4
  • 6Cappelli E, Taylor R, Cevaseo M, et al. Involvement of XRCC1 and DNA ligaseIII Gene products in DNA base excision repair[J]. BiolChem, 1997, 272(38): 23970-23975.
  • 7Olshan AF, Watson MA, Weissler MC, et al. XRCC1 polymorphisms and head and neck cancer[J]. Cancer Lett, 2002, 78(2): 181-186.
  • 8Ratilasinghe D, Yao SX, Tangrea JA, et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk[J]. Cancer Epidemiol Biomarkers Prey, 2001, 10(2): 119-123.
  • 9A1 Mutairi FM, Alanazi M, Shalaby M, et al. Association of XRCC 1 gene polymorphisms with breast cancer susceptibility in Saudi patients[J]. Asian Pac J Cancer Prey, 2013, 14(6): 3809-3813.
  • 10Caldecott KW, Aoufouchi S, Johnson P, et al. XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro[J]. Nucleic Acids Res, 1996, 24(22): 4387-4394.

二级参考文献32

  • 1王启俊,祝伟星,邢秀梅.北京城区女性乳腺癌发病死亡和生存情况20年监测分析[J].中华肿瘤杂志,2006,28(3):208-210. 被引量:81
  • 2陈建国,朱健,张永辉.启东市1972~2000年主要恶性肿瘤生存率分析[J].中国肿瘤,2006,15(9):575-578. 被引量:34
  • 3全国肿瘤防治研究办公室 卫生部卫生统计信息中心.中国试点市、县恶性肿瘤的发病与死亡(1993-1997)[M].北京:中国医药科技出版社,2002..
  • 4赵平,陈万青,孔灵芝.中国癌症发病与死亡2003-2007[M].北京:军事医学科学出版社,2012:79-90.
  • 5国家癌症中心,卫生部疾病预防控制局.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012.30.
  • 6FERLAY J, SHIN H R, BRAY F, et al. GLOBOCAN 2008 vl.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010 [ EB/OL ] . http:// globocan.iarc.fr, accessed on 10/05/2013.
  • 7Peter Boyle and Bernard Levin. Eds. World Cancer Report 2008 [ M ] . Lyon: IARC Press, 2008.
  • 8HOWLADER N, NOONE A M, KRAPCHO M, et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD [ EB/OL ] . http://seer.cancer. gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
  • 9PETO R, BOREHAM J, CLARKE M, et al. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years [ J ] . Lancet, 2000, 355(9217): 1822.
  • 10全国肿瘤防治研究办公室.中国恶性肿瘤发病死亡登记资料(第一辑)[M].哈尔滨:1989.

共引文献854

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部